Top Markets
Coin of the day
Brickell Biotech, Inc. Brickell Biotech, Inc.

Brickell Biotech, Inc.

BBI
Rang în acțiuni #40377
Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical... Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.
Preț acțiune
$2.35
Ultima sincronizare: 2022-09-07
Capitalizare de piață
$162.94K
Schimbare (1 zi)
2.17%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Brickell Biotech, Inc. (BBI)

Categorie

Istoric al prețului acțiunii pentru Brickell Biotech, Inc. (BBI)
Cel mai mare preț de închidere: $2.40 pe 2022-09-01

Cel mai mic preț de închidere: $194.34 pe 2019-09-01
Istoric al prețului acțiunii pentru Brickell Biotech, Inc. din 2019 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2022 -80.40%
2021 -62.42%
2020 -56.44%
2019 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE